SIRT3 and metastatic malignant neoplasm in the lymph nodes: However, in subgroup analyses, for lymph node metastasis of breast cancer in the SIRT3 positivity/high group, as compared with the SIRT3 negative/low group, was statistically significant (OR = 2.20, 95% CI = 1.49–3.26, P<0.0001).